In the above-mentioned article, there are two corrections to the text:
On page 294, in the second sentence under the heading “GLP-1 Receptor Agonists,” it reads “…dulaglutide (Tresiba)….” This should read “dulaglutide (Trulicity).”
On page 295, in the paragraph beginning, “A smaller but similarly designed study…,” in the sentence beginning “Glucose values were in the 70–80 mg/dL range…,” the sentence should read “Glucose values were in the 70–180 mg/dL range….”
The online version of this article has been corrected to reflect these changes.
© 2017 by the American Diabetes Association.
2017
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
